partnershipsChong Kun Dang Pharm licences Synaffix ADC platformLatest NewsSouth Korean Chong Kun Dang Pharm has licenced access to Amsterdam-based Synaffix BVs propietary ADC platform. Read more 6 February 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/Synaffix.png 322 608 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-02-06 12:47:262024-07-15 12:51:59Chong Kun Dang Pharm licences Synaffix ADC platform